iBV is very proud to announce the launch of ExAdEx-Innov, a new start-up led by Vincent DANI, post-doc at iBV since 2019 15/09/2022 by Jean-Claude SCIMECA
An RNA-immunoprecipitation protocol to identify RNAs associated with RNA-binding proteins in cytoplasmic and nuclear Drosophila head fractions 12/09/2022 by Jean-Claude SCIMECA
SK2 channels set a signalling hub bolstering CAF-triggered tumourigenic processes in pancreatic cancer 02/09/2022 by Jean-Claude SCIMECA